Phase Holographic Imaging PHI AB

Equities

PHI

SE0005504636

Advanced Medical Equipment & Technology

End-of-day quote NORDIC GROWTH MARKET Other stock markets 06:00:00 2024-01-30 pm EST			5-day change	1st Jan Change
6.46 ^SEK	-4.44%		-.--%	+8.39%

May. 17	Phase Holographic Imaging Obtains SEK7 Million Loan Agreement	MT
Mar. 27	Phase Holographic Imaging PHI AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	CI

Phase Holographic Imaging Announces Executive Changes

April 22, 2019

By reason of chairman Klas Cramborn's death, the Board of Directors of Phase Holographic Imaging (PHI) has decided to appoint Mats Lundwall as acting chairman of the Board. Mats Lundwall, former CEO of Cellartis, Santaris Pharma, Ferring Pharmaceuticals and Euro Diagnostica, has been a member of the Board since 2014. Lundwall has led the board meetings when Klas have not been unable to attend due to his illness. Lundwall will now also formally lead the Board's until the annual general meeting this fall.

Latest news about Phase Holographic Imaging PHI AB

Phase Holographic Imaging Obtains SEK7 Million Loan Agreement	May. 17	MT
Phase Holographic Imaging PHI AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	Mar. 27	CI
Phase Holographic Imaging PHI AB Appoints Ivan Jurkovic as Ordinary Board Member	Mar. 14	CI
Phase Holographic Imaging Presents a Comprehensive Opinion Piece Delivering the Versability and Potential the Company sees for Quantitative Phase Imaging Technology in Regenerative Medicine	Mar. 11	CI
Phase Holographic Imaging Reports Sales Results for the Third Quarter of 2024	Jan. 30	CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	Dec. 21	CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the First Quarter Ended July 31, 2023	23-09-20	CI
European Patent Office Intends to Grant Phase Holographic Imaging AB Patent on Synthetic Antibodies	23-07-04	CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the Fourth Quarter and Full Year Ended April 30, 2023	23-06-26	CI
Phase Holographic Imaging Phi AB Elects Goran Dubravcic Elected as A New Member of the Board	23-05-09	CI
Altium Mitkap AG acquired a 11.8% stake in Phase Holographic Imaging PHI AB from Formue Nord A/S.	23-03-07	CI
PHI expands its global network to India	23-01-24	CI
Phase Holographic Imaging Announces Management Changes	23-01-17	CI
Phase Holographic Imaging PHI AB Announces Management Changes	23-01-17	CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022	22-12-21	CI
Phase Holographic Imaging Announces Opening A New Development Office in the U.S	22-11-21	CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the First Quarter Ended July 31, 2022	22-09-29	CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the Fourth Quarter and Full Year Ended April 30, 2022	22-06-29	CI
PHI Enters Biomanufacturing Partnership with Wake Forest Institute for Regenerative Medicine	22-04-06	CI
Phase Holographic Imaging Installs Holomonitor Fluorescence Now At Novo Nordisk A/S	22-03-30	CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2022	22-03-21	CI
Phase Holographic Imaging Phi AB Announces Sales Results for the Three Months and Full Year Ended January 2022	22-03-15	CI
Phase Holographic Imaging PHI AB Moves to New Premises	22-03-10	CI
Phase Holographic Imaging Introduces Non-Invasive Fluorescence Units	22-01-20	CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2021	21-12-29	CI

Chart Phase Holographic Imaging PHI AB

Duration

Period

More charts

Company Profile

Phase Holographic Imaging PHI AB (PHI) is a Sweden-based company active in the field of medical technology. It develops and markets time-lapse cytometers for clinical applications. The products use holographic microscopy technology, with image sensors capturing light information from objects, and computer processing the information to create visual image. It is also engaged in the development of related software. Its method allows to view and measure living cell over time, without disturbing or destroying it. PHI collaborates with cancer- and stem cell researchers, among others. The Companyâs product portfolio includes HoloMonitor M3, a bench-top time-lapse cytometer, and HoloMonitor M4, allowing cell analysis in the cultivation incubator.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-06-26 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
PHASE HOLOGRAPHIC IMAGING PHI AB	+8.39%	15.8M
SARTORIUS AG	-19.42%	18.12B
QUIDELORTHO CORPORATION	-41.90%	2.87B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+19.36%	1.9B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-1.05%	1.65B
BIOTAGE AB	+33.96%	1.34B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-16.83%	957M
CONTEC MEDICAL SYSTEMS CO.,LTD	-21.96%	896M
REVENIO GROUP OYJ	+7.07%	841M
VAREX IMAGING CORPORATION	-26.98%	612M

Medical Diagnostic & Testing Equipment